Daxor Corporation (DXR) vs Nephros Inc. (NEPH)

Daxor Corporation and Nephros Inc. are both Medical Instruments & Supplies companies. Daxor Corporation is the larger, with a market value of $59.6M against $38.1M — 1.6× the size. Daxor Corporation trades at the lower P/E: 4.7× against 23.4×. Nephros Inc. grew revenue faster over the last twelve months: 24.2% against −52.1%. Nephros Inc. has the higher net margin (8.38% vs −251.9%) and the higher return on invested capital (14.1% vs 0.00%). Across the 17 metrics below, Nephros Inc. leads on 10 and Daxor Corporation on 7.

Valuation

Metric DXR NEPH Medical Instruments & Supplies median
P/E 4.67 23.43 33.75
P/S n/m 1.91 2.52
P/B 1.48 3.31 2.48
Price to free cash flow n/m n/m 25.19
EV/EBITDA n/m 19.82 14.62
EV/Sales (14.39) 1.69 2.88
Earnings yield 21.39% 4.27% (2.67%)
Free cash flow yield (16.76%) (1.98%) 0.09%

Profitability

Metric DXR NEPH Medical Instruments & Supplies median
Gross margin 0.00% 61.26% 54.29%
Operating margin 0.00% 7.92% 1.07%
Net margin (251.91%) 8.38% (1.61%)
Free cash flow margin 224.51% (3.19%) 1.08%
Return on equity 37.62% 16.10% (1.32%)
Return on assets 35.90% 12.39% 0.00%
Return on invested capital 0.00% 14.11% 0.00%

Growth

Metric DXR NEPH Medical Instruments & Supplies median
Revenue growth (TTM) (52.06%) 24.20% 8.85%
EPS growth (last fiscal year) 7.63% 1,471.43% 8.65%
Revenue growth, 5-year CAGR 0.00% 17.02% 9.17%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DXR NEPH Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 1.66 4.07 2.48
Net debt to EBITDA 0.00 (4.20) 0.89

Dividend

Metric DXR NEPH Medical Instruments & Supplies median
Dividend yield — — 1.11%
Payout ratio — — 0.27

Size

Metric DXR NEPH Medical Instruments & Supplies median
Market cap 59.57m 38.12m 619.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack